Published in Nephron on January 01, 1992
Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol (2008) 2.35
Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc (2007) 1.85
Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2011) 1.65
Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004. Clin J Am Soc Nephrol (2008) 1.36
Ileal interposition with sleeve gastrectomy for treatment of type 2 diabetes mellitus. Indian J Endocrinol Metab (2012) 1.12
GFR-estimating models in kidney transplant recipients on a steroid-free regimen. Nephrol Dial Transplant (2010) 1.04
Impact of occult renal impairment on early and late outcomes following coronary artery bypass grafting. Interact Cardiovasc Thorac Surg (2013) 1.03
A Multi-Stage Ultra-Endurance Run over 1,200 KM Leads to a Continuous Accumulation of Total Body Water. J Sports Sci Med (2008) 0.96
Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Ann Rheum Dis (2007) 0.95
Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus. Arthritis Res Ther (2013) 0.94
Implementation and evaluation of a nurse-centered computerized potassium regulation protocol in the intensive care unit--a before and after analysis. BMC Med Inform Decis Mak (2010) 0.92
Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease. Atherosclerosis (2011) 0.88
Changes in renal function following administration of oral sodium phosphate or polyethylene glycol for colon cleansing before colonoscopy. Can J Gastroenterol (2007) 0.87
A comparison of creatinine vs. specific gravity to correct for urinary dilution of cotinine. Biomarkers (2011) 0.86
Pregnancies in glycogen storage disease type Ia. Am J Obstet Gynecol (2008) 0.86
Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariates. Cancer Chemother Pharmacol (2014) 0.84
Ad libitum fluid intake leads to no leg swelling in male Ironman triathletes - an observational field study. J Int Soc Sports Nutr (2012) 0.84
Changes of renal AT1/AT2 receptors and structures in ovine fetuses following exposure to long-term hypoxia. Am J Nephrol (2009) 0.84
Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D. J Bone Miner Metab (2007) 0.84
Pharmacokinetics of the novel oral prostacyclin receptor agonist selexipag in subjects with hepatic or renal impairment. Br J Clin Pharmacol (2016) 0.83
Renal disease in systemic sclerosis with normal serum creatinine. Clin Rheumatol (2010) 0.82
Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial. Int J Clin Oncol (2010) 0.82
Outcomes of a disease-management program for patients with recent osteoporotic fracture. Osteoporos Int (2006) 0.82
Prevention of contrast-induced nephropathy: A randomized controlled trial of sodium bicarbonate and N-acetylcysteine. Int J Angiol (2009) 0.81
Accuracy and limitations of equations for predicting the glomerular filtration rate during follow-up of patients with non-diabetic nephropathies. BMC Nephrol (2009) 0.79
Quinolone prophylaxis for the prevention of BK virus infection in kidney transplantation: study protocol for a randomized controlled trial. Trials (2013) 0.78
Eligibility for Statin Treatment in Korean Subjects with Reduced Renal Function: An Observational Study. Endocrinol Metab (Seoul) (2016) 0.77
Soluble receptor for advanced glycation end products and increased aortic stiffness in the general population. Hypertens Res (2015) 0.77
Preexisting high expression of matrix metalloproteinase-2 in tunica media of saphenous vein conduits is associated with unfavorable long-term outcomes after coronary artery bypass grafting. Biomed Res Int (2013) 0.77
Quantification of excretory renal function and urinary protein excretion by determination of body cell mass using bioimpedance analysis. BMC Nephrol (2015) 0.77
Serum creatinine role in predicting outcome after cardiac surgery beyond acute kidney injury. World J Cardiol (2014) 0.76
The association between a low urine pH and the components of metabolic syndrome in the Korean population: Findings based on the 2010 Korea National health and nutrition examination survey. J Res Med Sci (2014) 0.75
Evaluation of renal function in patients with rheumatoid arthritis and amyloidosis. Clin Rheumatol (2001) 0.75
Delayed kidney injury following coronary angiography. Exp Ther Med (2016) 0.75
Early renal dysfunction after contrast media administration despite prophylactic hydration. Int J Cardiovasc Imaging (2013) 0.75
Cimetidine improves the accuracy of creatinine clearance as an indicator for glomerular filtration rate. Korean J Intern Med (1993) 0.75
A Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Individuals With Normal and Impaired Renal Function. Ther Drug Monit (2016) 0.75
Long-Term Effects of a Very Low Carbohydrate Compared With a High Carbohydrate Diet on Renal Function in Individuals With Type 2 Diabetes: A Randomized Trial. Medicine (Baltimore) (2015) 0.75
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med (1989) 4.41
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int (1995) 3.70
Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int (1998) 3.09
The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis (1996) 2.75
The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.26
Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant (1996) 2.21
Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: data for genetic counselling. Am J Med Genet (1984) 2.10
The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol (1995) 2.00
Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int (1996) 1.99
Syndrome associated with the abuse of analgesics. Ann Intern Med (1968) 1.82
Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol (1996) 1.64
Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol (2000) 1.52
Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int (1996) 1.46
Drinking water hardness and urolithiasis. Ann Intern Med (1978) 1.45
Nursing research: everybody's business. MCN Am J Matern Child Nurs (1994) 1.39
Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int (1984) 1.33
The importance of renal impairment in the natural history of Bardet-Biedl syndrome. Am J Kidney Dis (1996) 1.30
Association between hydrocarbon exposure and glomerulonephritis. An appraisal of the evidence. Nephron (1983) 1.24
Clinimetrics in nephrology. Nephron (1986) 1.18
Impact of renal transplantation on uremic cardiomyopathy. Transplantation (1995) 1.04
Cadaver kidney transplants. Transplantation (1967) 1.02
Analgesic nephropathy. A clinicopathologic study using electron microscopy. Am J Med (1971) 1.02
Improvements in drug prescription labels for patients with limited education or vision. Can Med Assoc J (1982) 1.01
Analgesic habits of 500 veterans: incidence and complications of abuse. Can Med Assoc J (1968) 1.01
Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol (1998) 0.98
Cerebral and pontine myelinolysis. Two cases with fluid and electrolyte imbalance and hypotension. J Neurol Sci (1973) 0.98
Hypernatremia, azotemia, and dehydration ue to high-protein tube feeding. Ann Intern Med (1968) 0.95
Glomerular injury in patients with neoplasia. Annu Rev Med (1976) 0.93
Cardiac disease in diabetic end-stage renal disease. Diabetologia (1997) 0.93
The natural history of myocardial disease in dialysis patients. J Am Soc Nephrol (1991) 0.91
Hydrolysis of digoxin by acid. J Pharm Pharmacol (1977) 0.91
Left ventricular hypertrophy in end-stage renal disease. Nephron (1988) 0.90
Kidney transplantation and long-term dialysis. Am Heart J (1970) 0.88
Clinical features and severity of nonspecific symptoms in dialysis patients. Nephron (1988) 0.88
Development of a health questionnaire specific for end-stage renal disease. Nephron (1989) 0.88
Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones. Medicine (Baltimore) (1991) 0.87
Hypocalcemia, morbidity, and mortality in end-stage renal disease. Am J Nephrol (1996) 0.87
Missense mutation in the adenine phosphoribosyltransferase gene causing 2,8-dihydroxyadenine urolithiasis. Hum Mol Genet (1994) 0.87
Analgesic nephropathy, 1972-76. Can Med Assoc J (1977) 0.87
Effect of some drugs on clinical laboratory values as determined by the Technicon SMA 12-60. Clin Chem (1972) 0.86
Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies. Transplantation (1987) 0.86
Clinical significance of urinary LDH, alkaline phosphatase and other enzymes. Can Med Assoc J (1969) 0.86
The clinical course of left ventricular hypertrophy in dialysis patients. Nephron (1990) 0.86
Hepatitis with Australia antigenemia following renal transplantation. Can Med Assoc J (1973) 0.86
Renal biopsy: current views and controversies. Nephron (1983) 0.84
Urolithiasis--a study of drinking water hardness and genetic factors. J Chronic Dis (1980) 0.84
Analgesic nephropathy in Canada: clinical syndrome, management, and outcome. Kidney Int (1978) 0.84
Persisting renal insufficiency after methoxyflurane anesthesia. Report of two cases and review of literature. Am J Med (1974) 0.83
The plasma phenolsulfonphthalein index (PSPI) of renal function: I. Theoretical considerations and investigative studies. Can Med Assoc J (1966) 0.83
Biotransformation and elimination of digoxin with normal and minimal renal function. Clin Pharmacol Ther (1979) 0.83
Significance of a negative cross match in recipients with a wide spectrum of lymphocytotoxic antibodies. Transplantation (1971) 0.83
Letter: Creatinine clearance and age. Lancet (1975) 0.83
Urinary enzymes in benign and malignant urinary tract disorders: alkaline phosphatase and lactic acid dehydrogenase. Br J Urol (1967) 0.82
Bacteriology of urinary tract stones. J Urol (1995) 0.82
Hyperchloremic acidosis in early diagnosis of renal allograft rejection. Ann Intern Med (1969) 0.82
Chronic pyelonephritis: relative incidence in transplant recipients. N Engl J Med (1966) 0.82
Comparison of infrared and wet chemical analysis of urinary tract calculi. Clin Chim Acta (1980) 0.81
Plasma digitalis-like factor(s) increase with salt loading. N Engl J Med (1983) 0.81
The feasibility and efficacy of early discharge planning initiated by the admitting department in two acute care hospitals. Clin Invest Med (1994) 0.81
Recurrent hemoperitoneum in women receiving continuous ambulatory peritoneal dialysis. Ann Intern Med (1987) 0.81
Human adenine phosphoribosyltransferase: characterization from subjects with a deficiency of enzyme activity. Biochem Genet (1983) 0.81
Serum and urinary enzyme activity after renal infarction. Can Med Assoc J (1965) 0.80
Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients. Am J Nephrol (1990) 0.80
Development of lymphocytotoxic antibodies in hemodialysis patients. Vox Sang (1972) 0.80
Evidence for the nephrotoxicity of analgesics. Can Med Assoc J (1972) 0.80
Studies of digoxin dosage, kinetics and serum concentrations in renal failure and review of the literature. Nephron (1976) 0.80
Serum enzymes in patients with carcinoma of lung: lactic-acid dehydrogenase, phosphohexose isomerase, alkaline phosphatase and glutamic oxaloacetic transaminase. Can Med Assoc J (1967) 0.80
Fractionation of tritiated digoxin and dihydrodigoxin with DEAE-sephadex LH-20. J Chromatogr (1976) 0.79
Pediatric urolithiasis in the 1970s. J Urol (1980) 0.79
Fluid and electrolyte complications of peritoneal dialysis. Choice of dialysis solutions. Ann Intern Med (1971) 0.79
Kidney transplants: computer display of clinical and laboratory parameters. The first 100 days. Can Med Assoc J (1969) 0.79
Preservation of the dog kidney. J Surg Res (1968) 0.79
Symptoms in end-stage renal disease: dialysis v transplantation. Transplant Proc (1987) 0.79
Serum ceruloplasmin in hepatobiliary and other disorders: significance of abnormal values. Gastroenterology (1966) 0.78
The oxalate:phosphate ratio in urinary tract calculi by infrared revised analysis. Clin Chim Acta (1987) 0.78
Low-output left ventricular failure in end-stage renal disease. Am J Nephrol (1987) 0.78
First morning urine pH in the diagnosis of renal tubular acidosis with nephrolithiasis. Clin Nephrol (1994) 0.78
Declining incidence of analgesic nephropathy in Canada. Can Med Assoc J (1982) 0.78
Comparative value of lymphocyturia, serum, and urinary enzymes in the diagnosis of renal homograft rejection. Surg Forum (1965) 0.77
Solitary intrarenal cyst: correctable cause of hypertension. Urology (1975) 0.77
Cardiac disease in chronic uremia. Pathophysiology and clinical epidemiology. ASAIO J (1994) 0.77
Letter: The clinical course of patients with analgesic nephropathy. Can Med Assoc J (1975) 0.77
Plasma conjugated androgens in a dialysis-dependent male as immunoreactive digitalis-like factors. Clin Nephrol (1990) 0.77
Dehydroepiandrosterone sulfate as a digitalis like factor in plasma of healthy human adults. Res Commun Chem Pathol Pharmacol (1985) 0.77
Erythromycin-cyclosporine interaction in renal transplant recipients. Transplantation (1987) 0.77
Higher values for digitalis-like factors with TDx Digoxin II. Clin Chem (1986) 0.76
Methemoglobin formation in analgesic nephropathy. Clin Pharmacol Ther (1974) 0.76
Congestive heart failure in dialysis patients. Arch Intern Med (1988) 0.76
Radiation nephritis following combined abdominal radiation and chemotherapy (bleomycin-vinblastine). Cancer (1978) 0.75
Nephrolithiasis in rural practice. Can Med Assoc J (1980) 0.75
Toxic nephropathy after low-dose methoxyflurane anesthesia: drug interaction with secobarbital? Can Med Assoc J (1976) 0.75
Trace elements and hemodialysis. Nephron (1991) 0.75
Drug metabolites and immunoassays. Clin Chem (1994) 0.75